Over the last week or so, congressional Republicans, with increasing audacity, have vowed that there would be repercussions for tech companies that complied with a request by the congressional committee investigating the January 6 attack on the Capitol.
As the criminal trial of Elizabeth Holmes—the disgraced former CEO of the defunct blood-testing startup Theranos, who allegedly defrauded investors, physicians, and patients—unfolds in San Jose, California, rubberneckers have no shortage of content over which to obsess. The tale of the blonde Stanford dropout who parlayed a try-hard Steve Jobs impression into a $9 billion valuation for a company whose proprietary technology never actually worked has been elevated to “cultural phenomenon” status since the story first broke in 2015. Читать дальше...
On a rainy March afternoon, Rogério Mendes strides through the dripping vegetation of a tract of virgin Amazonian forest and stops at a tree with scars arranged in neat diagonal rows across its trunk. From his back pocket he produces a wood-handled tool with a blade on one end, called a cabrita, and cuts another diagonal line though the bark, beneath the others. A milky white goo—raw liquid latex—begins to trickle down this tiny canal and into a metal pail below.
Читать дальше...